Podcasts about covishield

കോവിഷീല്‍ഡ് വാക്സിനെടുത്തവരില്‍ അപൂര്‍വം ചിലര്‍ക്ക് ഗുരുതര പാര്‍ശ്വഫലങ്ങള്‍ ഉണ്ടായേക്കാം എന്ന ഒരു സാങ്കേതിക പ്രസ്താവനയെ 'കോവിഷീല്‍ഡ് ഗുരുതര പാര്‍ശ്വഫലങ്ങള്‍ ഉണ്ടാക്കും' എന്ന തരത്തില്‍ ഭീതിപ്പെടുത്തുന്ന തലക്കെട്ടില്‍ മാധ്യമങ്ങള്‍ അവതരിപ്പിച്ചത് കഴിഞ്ഞ ദിവസമാണ്. വാര്‍ത്തയ്ക്ക് പിന്നാലെ തന്നെ സത്യാവസ്ഥ വ്യക്തമാക്കി ആരോഗ്യമേഖലയിലെ വിദഗ്ധര്‍ മുന്നോട്ട് വന്നെങ്കിലും പലര്‍ക്കും ആശങ്ക ഒഴിഞ്ഞിട്ടില്ല. എപിഡിമിയോളജിസ്റ്റും പൊതുജനാരോഗ്യ ഗവേഷകനുമായ ഡോ. ജയകൃഷ്ണന്‍ ടി. വിഷയത്തില്‍ വിശദമായി സംസാരിക്കുന്നു.

Covid-19 may not be raging any more, but a controversy over the AstraZeneca vaccine, sold as Covishield in India is. The issue first erupted when AstraZeneca, in a submission to a court in the UK, acknowledged that its vaccine could cause a rare, potentially life-threatening condition, known as thrombosis with thrombocytopenia syndrome or TTS. This led to everything from outrage on social media, to political parties issuing statements and to a host of misinformation being circulated. What is significant is that this information about TTS is not new – it was established as early as in 2021, when India's vaccination programme was underway, and it has been a known fact now for well over three years. Just a short time after the court submission made headlines, AstraZeneca also announced the worldwide withdrawal of its vaccine, citing a decline in the demand. As of this year, India has administered over 1.5 billion doses of Covishield to its eligible population.  What led to the furore over the vaccine's rare side effect and what do we know about it? How robust is India's system to monitor adverse events arising from vaccinations? And what happens to India's vaccination programme if Covishield is no longer available – are there other options available for those who need them or for future immunisations?  Guest: Dr Anurag Agrawal, Dean, BioSciences and Health Research, Trivedi School of Biosciences at Ashoka University  Host: Zubeda Hamid  Edited by Sharmada Venkatasubramanian. 

*Words of Wisdom / Gyan Ganga – Episode 234* AstraZeneca COVIShield Withdrawal- What it Means for India?' - Dr Subramanian Swamy

 १) 'रिंकल अच्छे है' : प्रत्येक सोमवारी इस्त्री न केलेले कपडे घालण्याची सूचना २) शिरुर लोकसभा मतदारसंघाचा आढावा  ३) IPL 2024 : कशी असेल पंजाब आणि बंगळुरु संघातील लढत? ४) सॅम पित्रोदांचा अखेर इंडियन ओव्हरसीज काँग्रेसच्या चेअरमनपदाचा राजीनामा ५) विधान परिषद शिक्षक, पदवीधर मतदारसंघाची द्वैवार्षिक निवडणूक जाहीर ६) Covishield : सीरमने २०२१ मध्येच थांबवले कोव्हिशिल्ड कोरोना लसीचं उत्पादन ७) माझ्या कॅन्सरचं निदान झालं तेव्हा नवऱ्याचा चेहरा...; सोनाली बेंद्रेनं सांगितली आपबिती स्क्रीप्ट अँड रिसर्च - अमित उजागरे

//The Wire//2100Z May 8, 2024////ROUTINE////BLUF: ASTRAZENECA PULLS COVID VACCINE FROM MARKET.// -----BEGIN TEARLINE------International Events-Europe: The AstraZeneca COVID vaccine Covishield has been withdrawn from worldwide production. AstraZeneca claims that this drug was pulled from the market due to declining demand and a wide surplus of similar products from other brands.-HomeFront-USA: Pro-Palestine demonstrations continue at a variety of universities around the United States. Over the weekend, graduation ceremonies were disrupted at many universities as demonstrators begin to solidify what has so far been a less-than-coherent collection of positions/causes related to the pro-Palestine movement. AC: Lately, demonstrations in some cities have shifted to demanding universities divest from financial investment in (or any cooperation with) Israel as a condition for ceasing demonstrations. These efforts are unlikely to achieve the desired result, as 38 states have enacted anti-BDS laws specifically outlawing divestment from the state of Israel only. Consequently demonstrations, disruptions, and general unrest are likely to continue as the various controlling interests (from all participating factions) continue to entrench in varying ideological positions, and dig in for the long-haul this protest season.-----END TEARLINE-----Analyst Comments: AstraZeneca claims there is no link whatsoever to their drug being pulled from the market a few days after multiple international health groups (and AstraZeneca themselves) have admitted that a major side-effect of this vaccine is Thrombosis with Thrombocytopenia Syndrome (TTS), which results in “severe blood clotting events”. Before being pulled from the market, this vaccine was administered in over 150 nations.Analyst: S2A1//END REPORT//

what is TTS : rare side effect of Covishield !! | ep: 300 | Tamil podcast | #covishield #injection

This is the Catch Up on 3 Things for the Indian Express and I'm Flora Swain.It's the 3rd of May and here are the top stories of the week.Union Home Minister Amit Shah at a rally in UP's Bareilly attacked Rahul Gandhi, saying he started his party's campaign with Bharat Jodo Yatra that will end with a ‘Congress Dhoondho Yatra,' suggesting that the party will get a severe drubbing in the Lok Sabha elections. Addressing a rally in Gujarat, Prime Minister Narendra Modi launched a new attack on Congress saying “it is a mureed (follower) of Pakistan.” In Shivamogga, Rahul Gandhi raked up the many allegations of sexual abuse against Prajwal Revanna and said, “PM Modi has asked for votes for a ‘mass rapist'.”Meanwhile, the Ministry of External Affairs confirmed on Thursday that Janata Dal (Secular) leader Prajwal Revanna, who is at the centre of a sexual abuse case, travelled to Germany on a diplomatic passport and no political clearance was either sought from or issued by the MEA with respect to his travel to the country. Meanwhile, the SIT probing the allegations of sexual abuse against Prajwal has issued a lookout circular after he failed to appear before it officials following a notice of appearance served on Tuesday.After around 100 schools across Delhi-NCR received hoax bomb threats by email on Wednesday, the Delhi government's Directorate of Education (DoE) has issued an advisory asking schools to ensure timely checking of emails received on their official email ID. It added that “if anything unwanted is noticed,” the deputy director of education in the district or zone and the Delhi Police are to be informed immediately.Global pharmaceutical manufacturer AstraZeneca has admitted that its Covid-19 vaccine, developed by researchers from the Oxford University, can cause a rare side effect of blood clotting and low platelet count after immunisation. In India, the same vaccine, called Covishield and manufactured by the Pune-based Serum Institute, has been administered through 175 crore doses. Reportedly, the company made this admission of a side effect, Thrombosis with Thrombocytopenia Syndrome (TTS), in court as it faces a lawsuit alleging severe harm and deaths caused by the vaccine.Breaking days of silence as police crack down on campus protests over the war in Gaza, US President Joe Biden on Thursday said “destroying property and threatening people was not a peaceful protest” and asserted that it was “against the law.” In his first remarks on the ongoing student protests over the war in Gaza, Biden said the protests have put to the test the right to speech and the rule of law, adding that both must be upheld. “American people must have the right to be heard, but rule of law must be upheld,” he said in an address at the White House.This was the Catch-Up on the 3 Things by The Indian Express.

First, Indian Express' Anonna Dutt joins us to talk about AstraZeneca, the pharmaceutical company that produced the Covid-19 vaccine - Covishield and its admission of the fact that its vaccine causes blood clots. She also shares the severity of the situation and whether or not it's a cause for concern. Next, Indian Express' Anjali Marar talks to us about why the month of April was warmer than usual and what to expect from the upcoming months according to the India Meteorological Department. (8:16)And finally, we talk about the BJP fielding Karan Bhushan Singh from Kaiserganj instead of father Brij Bhushan Sharan Singh. (17:43)Hosted by Niharika NandaProduced and written by Niharika Nanda and Shashank BhargavaEdited and mixed by Suresh Pawar

- Tòa án Tối cao Ấn Độ vừa nhận được một đơn đăng ký xin lập hội đồng chuyên môn y khoa để đánh giá các tác dụng phụ của vaccine Covishield, phiên bản sản xuất và lưu hành tại Ấn Độ của vaccine Covid-19 do hãng dược phẩm AstraZeneca và Đại học Oxford nghiên cứu phát triển. Chủ đề : Ấn Độ, vaccine Covid-19, AstraZeneca --- Support this podcast: https://podcasters.spotify.com/pod/show/vov1tintuc/support

चुनाव के लिए कुछ भी करेगा अब Covishield से मोदी को घेरने का प्रयास वोट जिहाद का आह्वान

Prajwal Revanna ‘sex videos' case: Lookout notice issued against Deve Gowda's grandson, Delhi schools bomb threat: Delhi police warns against false WhatsApp messages amid ongoing probe, People will respond to Delhi CM's arrest through votes: Sunita Kejriwal, Kotak Mahindra Bank shares fall 4% to fresh 52-week low on another bad news, AstraZeneca admits its COVID vaccine, Covishield, can cause rare side effect

* ஆபாச வீடியோ வழக்கில் ரேவண்ணா மற்றும் பிரஜ்வலுக்கு சிறப்புப் புலனாய்வுக் குழு சம்மன்!* மணிப்பூர்: காவல்துறையே மூலக்காரணம் - சிபிஐ அறிக்கை! * அயோத்தி கோயிலில் குடியரசுத் தலைவர்... காரணம் என்ன? * June-1 விக்கிரவாண்டி தொகுதிக்கு இடைத்தேர்தல்? * விருதுநகர்: கல்குவாரியில் வெடி விபத்து... 4 பேர் பலி. * Senthil Balaji-க்கு ஜாமீன் கிடைக்குமா... உச்சநீதிமன்றத்தில் அமலாக்கத்துறை போடும் திட்டம்!-The Imperfect Show Podcast

First, Indian Express' Anonna Dutt joins us to talk about why Hong Kong and Singapore withdrew products from MDH and Everest and how FSSAI has responded to it. Next, Indian Express' Damini Nath talks to us about the voting process and the verdict that was recently given by the Supreme Court of India regarding the EVMs and VVPATs. (5:15)And finally, we talk about  AstraZeneca, the pharmaceutical company that created the Covid-19 vaccine - Covishield and its admission of the fact that their vaccine causes series health issues. (12:12)Hosted by Niharika NandaProduced and written by Niharika Nanda and Shashank BhargavaEdited and mixed by Suresh Pawar

ब्रिटेन की फार्मा कंपनी एस्ट्राजेनेका ने माना है कि उनकी कोविड-19 वैक्सीन से खतरनाक साइड इफेक्ट्स हो सकते हैं। हालांकि ऐसा बहुत रेयर (दुर्लभ) मामलों में ही होगा। एस्ट्राजेनेका का जो फॉर्मूला था उसी से भारत में सीरम इंस्टीट्यूट ने कोवीशील्ड नाम से वैक्सीन बनाई है।ब्रिटिश हाईकोर्ट में जमा किए गए दस्तावेजों में कंपनी ने माना है कि उनकी कोरोना वैक्सीन से कुछ मामलों में थ्रॉम्बोसिस थ्रॉम्बोसाइटोपेनिया सिंड्रोम यानी TTS हो सकता है। क्या है ये TTS ? जिन्हें कोवीशील्ड लगी वो क्या करें जानें आज के FYI  में जहाँ हमारे साथ हैं Dr. Paramjeet Singh, Cardiologist, Yashoda Super Speciality Hospitals, Ghaziabad

Show notes and Transcript Andrew Bridgen MP is one of those rare individuals in UK politics.  He is driven by convictions and critical thinking as opposed to fame and power which is the norm in Westminster (or on Capital Hill I assume).  He was an absolute Brexiteer and led part of that campaign for The UK to have freedom from the EU.  He joins Hearts of Oak to discuss how he fought for Brexit all through his political life, but his biggest battle has been against the Covid Tyranny imposed on us by the UK government.  Andrew spoke up for all who have been vaccine injured and for that he was thrown out of the Conservative party and vilified in the media.  But the Conservatives loss was the gain of The Reclaim Party as he now represents them as the MP for North West Leicestershire. His bravery and boldness is plain for all to see and as long as we have people like Andrew Bridgen in Parliament, we have a glimmer of hope in the UK. Andrew Bridgen was elected in 2010 after spending 25 years running his successful family business, AB Produce, based in the constituency at Measham. Prior to this Andrew attended local state schools and Nottingham University. He has also trained as an officer in the Royal Marines. During his time in Parliament, Andrew has been a prolific speaker and has campaigned on a variety of local and national issues in Parliament. Locally Andrew campaigned for grant funding to bring all of NW Leics District Council housing up to the Decent Homes Standards. Andrew has also campaigned for better transport infrastructure which led to the duelling of the A453 and the planned electrification of the midland mainline. He has also worked with business and community groups to bring down the rate of unemployment in the District, as well as holding a jobs fair. On a national level, Andrew led the successful campaigns to decriminalise non-payment of the TV Licence and to scrap Air Passenger Duty for Children. He has also used his business experience to serve on the Regulatory Reform Committee as well as the Deregulation and the Enterprise Bill committee. Connect with Andrew... X: https://x.com/ABridgen?s=20 The Reclaim Party: https://www.reclaimparty.co.uk/andrew-bridgen Interview recorded 22.9.23 *Special thanks to Bosch Fawstin for recording our intro/outro on this podcast. Check out his art https://theboschfawstinstore.blogspot.com/ and follow him on GETTR https://gettr.com/user/BoschFawstin and Twitter https://twitter.com/TheBoschFawstin?s=20  To sign up for our weekly email, find our social media, podcasts, video, livestreaming platforms and more... https://heartsofoak.org/connect/ Support Hearts of Oak by purchasing one of our fancy T-Shirts.... https://heartsofoak.org/shop/ Please subscribe, like and share! Transcript (Hearts of Oak) Andrew Bridgen, it is wonderful to speak to you today. Thank you so much for your time. (Andrew Bridgen MP) Yeah, you're welcome.  Andrew Bridgen, of course you can find him @ABridgen on Twitter and he has served as Member of Parliament for North West Leicestershire since 2010, re-elected 2015, 2017 and 2019 with a whopping 62% off the vote, one of the few MPs with anywhere near that. Obviously, thrown out of the Conservative Party, the whip removed, and then that was in April 2023 for raising concerns on the Covid jab, and Andrew now represents the Reclaim Party in Parliament as an MP. Andrew, may I ask you first, what got you into politics? You entered Parliament in 2010. What made you think it would be a good idea to get into politics? Frustration, Peter, and I've been running a business for 22 years, which would start it up the thousand pounds. So I've been I've been MD and chairman of the company and we built it up to 25 million turnover company employing 300 people by 2006. And I'd give, I'd been interested in politics. I joined the Conservatives in 1983 at Nottingham University. And I'd been chairman of the Institute of Directors and on the council of the IOD in Pall Mall, and through working during the Blair years with the East Midlands Regional Assembly as a business member. Obviously I'd met a lot of ministers and I can't say that I was impressed. Well, it was pretty clear they were going to bankrupt us. So a group of friends, most, they were all really sort of small and medium-sized business people and their wives, we used to meet in a pub locally and every Friday night it was sort of a groundhog day, so they always moaned about the state of the country. I'd given a reasonable donation to the Conservative Party in 2005 and I think we had a half a percent swing to the Conservatives so worked out at that rate we're never going to get rid of Tony Blair. And so they moaned every Friday night and it eventually it got to me but I mean by that time I was running a business that was making about three million pounds a year across the group. I've got a good management team and no debt whatsoever and one pint of Marston's Pedigree on a Friday night too many and I said to this group of collected individuals, that's it then. It's no good relying on anybody else. There's only us. So in North West Leicestershire was supposed to be a rock solid Labour seat. The council I don't think had ever been conservative controlled properly. I think they may have had control for about three months once out of 40 years after a by-election. So I said well you all stand for the council, the district council, I'll stand for MP, we'll take over and we'll get it sorted and to a man and a woman every single one of them agreed. And so I put most of the money up for the, I put the money up for the campaign and I got the nomination. Nobody really wanted to be the MP for North West Leicestershire, well the candidate for North West Leicestershire because no one, the Conservatives told me we can't win North West Leicestershire, 83rd target seat. They also said they weren't giving me any money but I said that's fine, I've got my own money and my factory was in the, in the, so I actually did have a payroll vote. So 300 people plus their families in the constituency and the District Council elections came round first in 2007 and I was already selected as the parliamentary candidate. I ran those elections and put the money up and it was the first time the Conservatives had put a full slate up in the seat and they said I was running them too thin but I always thought basically if you didn't put a candidate up at an election it's very difficult to see how how they're going to vote for somebody aren't they? So we put a full slate of candidates up and took Labour down to five councils out of 38 in one night, the biggest swing in the country in the District Council elections in 2007. We took control of the council obviously, and I had the second biggest swing in against Labour in 2010, so I turned a rock-solid four and a half thousand Labour majority with a much loved Labour MP, who sadly died, into seven and a half thousand Conservatives at one, so that's like a 12.5% swing. The seat's my home and, you know, I'm very comfortable in North West Leicestershire. And we moved it to, in 2015, it went up to 11,200 majority. And despite Theresa May's best efforts in 17 with her manifesto, which was appalling, I moved it up to 13,300 majority. Then in 19, I led the leave campaign in the referendum for the East Midlands. I told my seat that if they didn't back me I would have to resign as their MP because we didn't agree on the big issues but to be honest Peter I was fairly sure they would. So the East Midlands voted 59-41 to leave and my own seat voted 61 39 and I'm actually the MP who persuaded Boris Johnson to back leave. He was no way that he was a natural Brexiteer and also if you look back on YouTube you'll find that on the eve of the referendum Boris Johnson came to my seat and we went round Ashby de la Zouch. That's when I told him we were going to win and you should have seen his face when I told him we were going to win. I don't think that that wasn't actually part of the plan Peter and in fact he tried to talk me out of it he said no no it's going to be close but we're not going to win. I said no no we're going to win tomorrow. No, it's going to be close. I said, well, maybe I said, but certainly not around here, not around here. It's not going to be close. You know, the bit we're running. So, and then in 19, on the get Brexit done election, which now seems so much happened since 19. It feels like a very long time ago, more than four years away. And I got a 20,400 majority, it was 62.8% of the vote. And the BBC, I had no sleep that night, the next morning the BBC interviewed me and they said, Mr Bridgen, you must be delighted, this is your fourth election victory, each time you've increased your vote, you've increased your majority, your percentage of the vote, you must be delighted. I said, no, it's terrible actually. They said, why is it terrible? I said, well, I've, you know, it's nine years since I was first elected as the MP, I've delivered the highest economic growth in the country. We've taken the poorest constituency in Leicestershire and made it the richest, the only part of Leicestershire with above-average UK salaries and wages. We've got the happiest place to live in the Midlands now, Colville, which was the most deprived town in Leicestershire. I said one in three of the electorate are still not voting for me. I'm gonna have to work much much harder.  Tell me about that whole Brexit battle. I mean my time was UKIP and UKIP was easy because 100% of Kippers were on board. The Conservative Party have always had that tension and division over Europe. What was that like actually in the Conservative Party pushing something that wasn't necessarily what the Conservatives wanted?  Well it wasn't what the establishment wanted, all the established parties were backing Remain. I think it was interesting that the Conservative Party was like, a very civilized internal war, and there were probably only a quarter to 30 percent of conservative MPs who were for leave, so still the majority were, remain, or indifferent, and some of them maintaining indifference, which I mean, I don't know what you're into politics for. If a big question like whether we should remain or leave the European Union, they say, I don't want to get involved in this. I'll just sit down and see what my people say. I mean, that's not exactly leadership, is it? I mean, I think that should be pretty much automatic deselection, if you can't make your mind up on that sort of issue. And what comes back to mind is that the Conservative Party, we used to, when I was in the Conservative Party, before they threw me out, well, first I'll tell you this, Conservatives have never been encouraged in the Conservative Party, they're only ever tolerated. And the Conservative Party, Parliamentary Party, had something called an away day every two years, and they pay for them in advance to get a good deal. So despite the fact that there was this internal schism over the referendum that was coming, the party had paid for an away weekend in Oxfordshire at this basically hotel that's like a Bond villain's hideout, with an underground lecture theatre, which is a very weird place, and because we paid for it, we were told we'd all got to go there, and this is only sort of three months before the referendum, and we had a very civilised weekend of talking about policy, but no one mentioned the EU and no one mentioned the referendum over the whole two and a half days and the dinner, but I do remember that Craig Oliver sat with me at the final dinner he sat next to me on my table at the final dinner and I told him, I said have you got yourself another job lined up for when you lose, and he said to me he said that's fine he said if we win by one vote that's it settled and that's that's it done. I said well I'll be honest I'll take though I'll take that on as as it cuts both ways, you know, if we win by one. And I knew we were going to win, Peter, because, I'd been around the East Midlands and I could tell we were definitely going to win. But it's about driving the vote up because it wasn't just winning by a seat, all the votes were cumulative, so every vote counted. And what I'd sussed out is in my seat and in the East Midlands is that people who didn't normally vote were going to come out and vote. They weren't, those people who didn't normally engage with politics, they weren't coming out to, they weren't coming out to vote for the status quo, they were voting for change. So I concentrated my campaigning efforts the last six weeks. And did a lot of campaigning and also I was running a load of field operatives who were, 90% of it, they were UKIP. The Remain campaign had nobody on the ground willing to deliver leaflets, hardly at all, for them. We were destroying them on the ground battle. Obviously, in the air campaign we could only be responsive because they got all the media, they got all the established parties, and we were the insurgents. So that was more of a struggle, but on the ground we were doing very, very well. And what I'd sussed out was that people were going to come out and vote who didn't normally vote and every time I saw the polls I was not disappointed because I knew that we were probably, we probably got five or six percent better than the polls were saying because these people who were going to come out and vote and they told me they were and I believe they were, They're not engaged in politics, they're not on YouGov's polling panel, and when Com Res or somebody else rang them up and they said, oh, I'm going to vote to leave the European Union, they'd say, well, did you vote in the last general election? No. Did you vote in the local? No. Did you vote in the one before? No. Have you ever voted? No. And they'd put them down as zero chance of voting. Well, I knew as long as we got those people out, it was all going to come as a bit of a surprise to the Remain campaign. In North West Leicestershire, and we counted our votes, so I know it's fine, I know exactly what the vote was in North West Leicestershire, but you could terminate my seat of North West Leicestershire until the next boundary changes. I think it was a sort of 70-75% turnout to get me in in 2010, important election. And then ever since then, as my majority had gone up, the turnout had gone down and it dropped to sort of 68.5% or something in 19. But I mean, it was a stonking massive majority. And obviously the referendum, I was very encouraged when it was nearly 80%. And I'd spent all my time in Northwest Leicestershire and across the East Midlands. In my villages, I mean, it's a general election, they turn out 85 percent anyway. I'm not going to squeeze much more out of those people. You know, it's very hard to squeeze that they're on the second, third pressings of the pips. So I went to all the areas that normally turn out 50, 55, 60 percent because there was plenty of low-hanging fruit and you know it was that turnout in North West Leicestershire and across the East Midlands some people who didn't normally vote and that's why we won and that's why the polling was so wrong and that's what people like David Cameron who'd come to my seat in 2008 when he was leader of the opposition and he really upset me Peter so I'm a a candidate. We've just taken the council with the biggest swing in the country for the first time in living memory and Cameron told me in front of constituents that my seat was a dump and it should never be conservative. And they weren't giving me any money and I said I don't need your money and to be honest David if that's your view, never ever come to my constituency again and I will with it. And to be honest, David Cameron is a man of his word, he never came, he never came again. So that's fine. And I think now my majority is bigger than Whitney, so I mean what a dump the Cotswolds must be. North West Leicestershire. And we've gentrified. So people used to say Coalville was a very poor place and it didn't have a chance and now it's Coalville and proud. In fact I'm speaking to you from Coalville today.  I want to get on to the COVID discussion situation, but just you, you talked at the beginning about having a business and I guess part of your reason for getting into politics was you wanted the government to butt out, you want local businesses to be able to get on, to have, not to have restrictions on them actually doing well, making money, employing people. What kind of other kind of interests or passions? Well, I've actually cut my teeth in politics when I was chair of the Institute of Directors, which they didn't like particularly because they were fairly pro-EU, is that I got involved as a businessman in the,business for sterling in the no campaign to keep the pound so 25 years ago and thank goodness we didn't join the euro otherwise I mean it'd be much much more difficult to extract ourselves. Yes and Simon Wolfson the chairman of Next we used to meet at Enderby in his boardroom and plot business for Sterling in the No campaign. So I suppose that's where I got involved. And a chap called Chris Eaton Harris, who's gone on to great things, apparently, he was an MEP. And his father had a fruit and vegetable wholesale pitch in Covent Garden Market. And since I was into washing, packing, and distributing vegetables, mostly potatoes, nothing sexy. Chris was one of my customers. I used to buy from Mark Potatoes from Mark Spencer. And Philip Dunn as well. They're farmers. So we had the whole supply chain between us, do you know what I mean? But I made most of the money.  Which is just as well because they're not in parliament. Just as well. So yeah, I wanted to put something back and yeah, that's where we ended up. Obviously being a Brexiteer, there was backlash in the media, there was probably some pushback within the party itself. But I guess none of that even prepared you for the backlash whenever you addressed COVID tyranny. Is that a fair assessment?  Well I know that the two years under Theresa May were purgatory quite honestly. I mean I was a Spartan so I voted three times against Theresa May's deal which you know it wasn't, you know, some colleagues were conflicted and there was Steve Baker crying his eyes out. Well I mean there's nothing to cry about because I've already voted against it twice, it hasn't got any better and once you've come to the conclusion, which was the correct conclusion, that Theresa May's deal was constitutionally and democratically worse than being in the European Union. I mean at least if you're in the European Union you have a chance of leaving whereas Theresa May's deal we would be in vassalage forever and there's no way of leaving. Well I mean that's not a deal, not in my name and that vote on the third time Theresa May's deal came up before the Commons I was pretty convinced that there were probably going to be 28 Conservatives in the no lobby. The rest of Parliament would vote yes and that we would have been slung out of the Conservative Party within a few days. That was where I thought we were. Thank goodness. I mean we always criticise Jeremy Corbyn but he is a man of principle and he is secretly a Brexiteer really I think and he marched the Labour Party in behind us and the rest, as they say, is history. But I mean, a politically savvy Keir Starmer would never, would have taken Theresa May's deal and consigned us to EU vassalage. So thank goodness it was Jeremy Corbyn. But he did win the Conservatives the 19th election. That wasn't, down to Boris, it was pure fear of Jeremy Corbyn.  Yeah, no, it was, you don't want Corbyn, 100% I remember that well.  Well, I actually had two, during that 19 election, I can remember when I was going around the doorsteps, two members, two paid-up locally members of the Labour Party came to me and said I'll be voting Conservative, I can't vote for Jeremy Corbyn.  And they actually told me they were paid up members of the Labour Party locally. Well I mean if you, I mean that is your core, ultra core vote. They weren't even voting for him. Wow. On to the COVID. I've never seen anything and I mean I've loved politics, forever with Northern Ireland parties, the DUP and we've had Ian Paisley and Sammy Wilson on before and then conservatives then over to UKIP, but nothing has divided people like what we've had in the last three years with the COVID tyranny. But you spoke a step, it wasn't just on the restrictions that we had, that civil liberty, but you also saw what was happening with harms and went on that. Tell us about that, how you worked that out, because that was a big step and that was an unacceptable step.  I think there's an element of destiny about all of this Peter. When I was 18 and I'm the only member of my family that's been to university, I had a foreground because my parents weren't very wealthy, they were poor. So about two and a half percent of people went to University when I went in the 80s and I went to Nottingham locally but I studied biological sciences with biochemistry specializing in genetics, virology and behaviour. Oh dear! And I don't know why, just they were things I found quite fascinating so I've tried to keep my knowledge up so I mean in February when we'd had the 19 election and then we had a sort of six weeks period and then we had then we had COVID and everything changed. Well in the February I was sent and I looked through the scientific papers for the efficacy of hydroxychloroquine, its effectiveness against coronaviruses and it was compelling. They were scientific papers and because I've got, my degree a very long time ago in those subjects I mean I can read them and I can understand the papers and I sent the papers to Mark Spencer, Chief Whip, and said the government need to look at this urgently, this could be could be very useful and also sent them to Jeremy Hunt who was at the time, Chair of the Health Select Committee, and I didn't get anything back from Spencer. And I also told Spencer, I said, you realise that I've got qualifications in all the areas that'll be useful, if you want some help in the number 10, with someone who can actually read the papers and understand it and put it across politically, I'll be quite happy to help. They never, Mr Stewart never asked me to help, and I rang up Jeremy Hunt a week later, and this shocked me, Peter and it will shock your listeners. So I rang him Hunt up and said Jeremy I sent you these papers, have you have you looked at them? And he said Andrew he said don't send me scientific papers he said I don't understand them and I said but Jeremy you're chairman of the health select committee and you were health secretary for seven years. I said what? You don't understand scientific papers, and what you have no access to anyone who does understand them he could actually explain them to you and he put the phone down and that was it and so my suspicion, so I hadn't got a great deal of confidence I did support the first lockdown because I don't think anybody knew, well somebody knew what was going on it certainly wasn't me, you know was it three weeks to flatten the curve. Anyway, so, and I was, from then on, things just didn't seem to stack up. The masks, I couldn't see the sense behind the masks. I mean, those paper masks, they are to stop saliva from the doctors and nurses going on to the patient's wounds and to stop blood and other bodily fluids squirting into the medic's mouths, which they don't really like, they don't like that. That's what they're there for. So not to stop viruses and the gaps around the edges And I was briefly in the military. And if you had a full nuclear biological chemical suit, you've only got an 80% chance of keeping a virus out. Well, I mean, that's not what these paper masks are. And I guess, I hated putting them on anyway. They're horrible. So I was on that. And then the continuous lockdowns, and Northwest Leicestershire was chucked in with Leicester. And so we were locked down as much as anywhere in the country. It was completely unprecedented and unwarranted. I also really objected to the schools being closed. And I objected. I mean, they were making the children wear masks. And even some schools were making the children wear masks when it wasn't mandated. And none of this seemed right. And there are some, speaking to some scientists who were speaking out about their concerns, And the fact that they were silenced, and they said all the science is all settled, I mean we've heard that one before several times, I'm sure we'll hear it again, but I mean science is never settled. It's a bit like politics, there's always another view, and if you can't defend your position, then there's something wrong. You know, every scientific thesis is open to challenge, or should be able to challenge, and most of them, I mean half of everything that doctors are taught in medical school within 10 years will be proved to be completely wrong. That's a fact, I mean that's just a fact. So, you know, the only constant is the evolution of science and new theories to supersede old ones and saying that, you know, we're not having any debate about this and cancelling eminent scientists. Then my concerns grew and grew and grew but I didn't want to believe the worst of the government. I actually am double vaccinated. They will call me an anti-vaxxer so which is difficult when I'm vaxxed. I'm more the sort of concerned vaxxed and I had two shots of AstraZeneca, I wish I had none, and I had a bad reaction after the second jab, which really, really hurt me. So I'd bitten my tongue, that also uncovered a lot of corruption around PPE. My whistle-blower was sacked. We uncovered £860 million worth of PCR tests that had disappeared from stock at Kuehne & Nagel were the distributor. We traced some of the unique barcodes and they turned up in Berlin. They'd been resold. So nearly a billion pounds. And my whistle-blower could only go back 12 months on his computer. And he was only in one of the three channels. He was in the channel to do with bulk. So it was only sort of prisons, schools, hospitals, things like that. But 860 million pounds worth of PCR tests had gone missing the taxpayer paid for. We took it to the government and the civil service. My whistle-blowers computer was switched off on the day and he was sacked within seven days, no investigation. I was pretty annoyed. And I mean, the corruption of the Boris Johnson regime was the first one I'd, and he was the he'd been the first Prime Minister I'd actually voted for and I was feeling very betrayed. So I hadn't voted for David Cameron, obviously, I voted for David Davies, and Cameron got in and I didn't vote for Theresa May. She got in. And so then Boris turned out to be as crooked as all the rest of them. So that wasn't good. And then my pretty view on the vaccines and the mRNA technology, the messenger ribonucleic acid technology. I was working behind the scenes and obviously Matt Hancock had to go and we had, Sajid Javid became health secretary. But there are about five Conservative MPs who are qualified doctors. Well Matt Hancock, not a good man, but he had said in the House of Commons that these vaccines were for adults, they weren't for children, so no one under 18 was going to have them. I know that every one of the doctors, qualified doctors, went to see Sajid Javid and told him not to use the experimental vaccines on under-18s and he listened to all of them and then approved it. It's interesting that these two health secretaries are both leaving the Commons at the next election, isn't it? I wonder where they'll land, you know what I mean? I suspect Peter, there'll be earning a lot more money than MPs get paid, let's just put it that way.  And then when the MHRA came out in November last year and wanted to extend the experimental vaccines to babies, down to six months of age, and I'll declare an interest, I've got a five-year-old and I thought now, I've got to speak out and I knew there'd be a huge backlash from the party, politically and I knew the vested interests that were involved in it but I also knew that it was probably going to cost me my position in the Conservative Party because they were so committed, but that I could win, that I'm pretty sure I thought, well there's no point doing it for nothing, you've got to win and I was pretty sure that I could put the science over that there were no healthy child of that age had died anywhere in the world of COVID-19 so there was minimal, minuscule risk from the virus but there was a risk from the vaccine. I thought even the most pro-vaccine person I could persuade that since the manufacturers still had immunity from prosecution that there had to be a risk. But there was no risk for those children. I thought I could get that message across and we could actually do some good and so I'd spoken out in a Westminster Hall debate, in I think it was October and then on November 13th I secured an adjournment debate and and blew the lid off the childhood vaccines, vaccination with the experimental mRNA. And that night, my life changed. I was basically immediately cancelled by the mainstream media. And from that moment onwards, I had hundreds of thousands of emails from around the world from people who were telling me about the vaccine harms and the vaccine deaths that they were seeing and that was it really. So after that, although the government will say that I'm a conspiracy theorist and anti-science, anti-vax, and all the people who call me anti-science and everything, I mean they haven't got any science degrees between them and the fact is that the government, our government was never able to approve those vaccines for healthy under fives, whereas all the other countries around the world did. So despite the fact that they said that I was talking absolute rubbish, they never bought the policy and every other country did. And then we got round to sort of January and the infamous tweet, which was actually, I mean, yes, so I retweeted, I actually didn't do it, but it was retweeted on my Twitter, a tweet from Dr. Josh Guetzkow of the Hebrew University of Jerusalem and it's fair to say that Mr. Guetzkow is a Jewish gentleman, that he'd been told by a top cardiologist that the rollout of the vaccine was the biggest crime against humanity since the Holocaust, and the party seized on that, the Conservative Party seized on that, to say I was an anti-Semite, and suspended me immediately from the party. I had a meeting at that time with a Conservative Party grandee who'd clearly been briefed by the party. We had an hour together in his office and I told him all of my concerns around the vaccine harms, the midazolam and morphine, the creation of the first wave of deaths by moving people out of care homes and then putting them onto the death pathway, putting them down, treating them with respiratory suppressants to give them the symptoms of COVID-19 which will appear on their on their death certificate and they were pretty much all cremated very shortly afterwards so there was no autopsies and we had an hour of that. I also knew that the person I was meeting with, because I'd done my research and I've got plenty of informers, he knew full well all of my concerns because he'd been told them. I also know that his sister had had to go into hospital after the second Pfizer jab with chest pains, but I didn't tell him any of this. And at the end of the meeting this grandee turned around to me, obviously with the party line, I've been suspended and said that there is currently no political appetite for your views on the vaccine, Andrew. They may well be in 20 years time and you're probably going to be proved right but in the meantime you need to bear in mind you're taking on the most powerful vested interest in the world with all the personal risk for you which that will entail, and at that point I said well the meeting's over then isn't it? I'm not, don't ever threaten me and I don't like being threatened by public school boys. You know, as a comprehensive school boy, if they had been at my school, they'd have spent most of their time with their head down the toilet. It was a very comprehensive education.  So we basically called it a day at that and then they just fast-tracked the investigation and found me guilty and permanently expelled me from the Conservative Party, which is interesting because in their investigation what they didn't discover is I never put the tweet out myself anyway. I've never ever had the codes to my own Twitter. It was actually posted by my association chairman who remains in the Conservative Party.  Can I ask you about... I need to ask you about the conversations with colleagues and obviously not breaking confidentiality of that, but working with Lord Pearson I'm always amazed people come to him after a debate and says well done. I could never say that but well done you said that. Did you have any kind of similar?  Yes, it's coming up to a year since I first spoke out so yeah I've probably had 20, I probably had 30 backbenchers have come up to me and said you're definitely onto something with these vaccine harms, keep going but that's a million miles from standing in the chamber and saying anything. I've had senior members of the Conservative Party have come to me and said that they're going to speak out. I've had a very senior MP came to me before summer recess and said he'd been approached by a constituent representing 1,100 vaccine-harmed people and he'd have to speak out, but he hasn't, and I had a very senior minister who came to me and said that they're, I mean this is all in private in parliament, no witnesses, so I mean they can deny it if they want to, but you have my word it's the truth, and come to me and said you do realize that my sister's just taken the Moderna booster and now she's paralyzed from the neck down. And I said well that's that's that's terrible news but clearly you're going to have to speak out now aren't you? and they said no, well she doesn't want any publicity and they think they're going to get her to walk again. I said well you don't have to name names I mean you know, you've got to speak out you know and the minister said I'm not speaking out and walked off. And I don't know what to go, I mean, we're supposed to speak without fear or favour, you know, I think the job of an MP is to, certainly I see the job as being to represent, the people, start with my people in North West Leicestershire, against the government and the establishment. And now what we seem to have is a lot of MPs who represent the government and the establishment against the people. That's an inversion of the job of a Member of Parliament. They said to me, you know, why are you willing to die on the hill of vaccine harms, you know, of an issue? And I said, well, because that's the hill you're killing my people on. No completely. I want to add two things to finish. One, you're in the Reclaim Party because that seemed to be the only option. Course you could do as an independent, that doesn't really happen in the UK, but also you're continually asking the government questions. One of the latest questions is did the MHRA inform the Minister of the Pfizer COVID-19 vaccine had been switched? Tell us about Reclaim and I'm assuming you're yet to receive an answer to that government question.  Well Reclaim are a political party, they didn't have any MPs but they're well funded and they've got some lovely premises and they've got great people and they're also aligned with something called the Bad Law Project, so I have access to lawyers and solicitors and so I'm taking Matt Hancock to court for defamation and we have a very strong case. I'm probably going to take the Conservative Party to court for the way they handled my dismissal from the party, which is unbelievable. I'm on my fifth subject access request to the Cabinet Office. I mean, Peter, I've put in for all the information they're holding on me, and even when I'm over four, this is the fifth one going in now, I keep cutting down the number of keywords and compressing the time, and every time they come back and say, I mean, they must have a library on me. They haven't got a black book, they've got a whole library on me. And every time they come back and say, it's too much work. I mean, the last one was about 10 key words. And I said, it's only from 1st of January, 2017. I'll publish all the papers one day and it'll be fascinating, but goodness knows what they're hiding. They're certainly not willing to release any documentation. So I think we're going to have a massive, massive, massive bust up with the government over that. And if they're doing it to me, it won't be just me, will it? There'll be. Yeah, I mean, if there is any mitigation of my colleagues, and I'm not thinking of any any mitigation at all for their inactivity when so many of them, I mean, what you've got to understand, Peter, is people say to me, So there was a lovely female Conservative MP who will remain nameless, but she was elected in 19. And she came up to me a few months ago and said, Andrew, I'm really worried about you. You speak in the chamber on your own. You have all your meals on your own. You sit on your own table in the tea room and the dining room. No one talks to you. You seem really isolated. I'm really worried about you. I said, well, that's very touching. I said, but you've got to remember, 4,000 real people work in Parliament. The cooks, the cleaners, the waiters, the security guards, the police, I said, and they all come to me and 80% of those agree with me. So I'm not really isolated at all, am I? I said, actually, you're isolated, you just don't realise it. So it's not been that bad in Parliament. As far as the Pfizer data, it was again Dr. Josh Guetzkow sent me some from the Hebrew University, sent me some evidence and he's not a scientist, he's a criminologist but he's a specialist in fraud and he went through the Pfizer papers and discovered how they'd switched the vaccines. There were two batches in the initial batch, one that they basically made a Rolls-Royce vaccine up which they gave to 22,000 individuals and they had 22,000 in the placebo group who got a saline shot and that's what they got approval for with the MHRA and every other regulator around the world. But that wasn't the vaccine, that wasn't the Pfizer vaccine that was rolled out. And the smoking gun for the switch of the vaccines is the fact that the MHRA changed the protocols on day two of the mass rollout of the vaccination in the UK, and said that everyone got to stay at the vaccine centre for 15 minutes after day two because of the risk of anaphylactic shock and you only get anaphylaxis if there's endotoxins in the vaccines and you only get endotoxins in the vaccines if they're cultured up in bacteria such as Escherichia coli and the MHRA hadn't expected anaphylaxis because that is not how the vaccine that was given approval for was manufactured, it wasn't manufactured in bacteria with all the contaminants that would go with it. Now, you can't, to get approval for a drug, you have to use the same mechanism of production. You can't change anything because then you've got a different drug with different side effects. So basically, what my allegation is, supported by 44 pages of evidence supplied to me by a doctor of criminology from the Hebrew University of Jerusalem, the government will not answer or even acknowledge, is that the vaccine that was rolled out in the UK and around the world was effectively completely untested and it also explains why the, I mean that the harms from the Pfizer trials of the very best vaccine they could make in in a very small, basically a bespoke vaccine that they made for 22,000 doses, I mean that was horrific enough and that should never have had approval but it was nothing like the harm profile we've seen in actuality through the VAERS system and the yellow card system and the fact that the vaccine is a different vaccine basically explains that as well. If they were doing that with Pfizer, I mean I have no doubt that Moderna and the same and of course I had the AstraZeneca vaccine which which was actually that bad. It was just quietly withdrawn, wasn't it? And it's interesting that the Johnson & Johnson vaccine, which is the AstraZeneca vaccine is not a messenger RNA. It's a DNA strand in an adenovirus vector. So it's different technology to the Pfizer and the Moderna. It's because obviously the DNA then will code for the messenger RNA. And so it's one step further back. It's interesting also that the, I asked for an urgent question in Parliament a few months ago because the Johnson & Johnson vaccine was withdrawn in America and I saw the FDA, the Federal Drugs Agency guidelines and it said stop basically, stop injecting the Johnson and Johnson and all stocks are to be destroyed. And the Johnson and Johnson that was also, a DNA strand not a messenger RNA strand and also in an adenovirus vector to get it into the into the cell. So it's interesting that basically both the vaccines, experimental vaccines were using the DNA adenovirus vector method, they were, both withdrawn and destroyed. But it is interesting that India are still producing effectively AstraZeneca under license. They call it Covishield in India. And of course they didn't stop the Australian version of the AstraZeneca vaccine until only a couple of months ago, so there's going to be a big kickoff there as well. So that's it. I sent it to the Attorney General because one of the questions I did ask was did the MHRA tell the Minister that they'd switched the vaccines, in which case if they didn't then the MHRA are guilty of potentially a crime which is I think it's a two-year prison sent us an unlimited fine, but if they did tell the minister, then how could the minister go out and say they're safe, effective, and tested when they knew that they weren't? I don't understand why the prime minister doesn't want to come back to me. I'm afraid the letter I sent him was a bit of a, do you still beat your wife question. There isn't a good answer, because either I'm going to nail the MHRA, or I'm going to nail the ministers. And it's also interesting, I think, you know, so many health ministers are deciding to not stand at the next general election. No, 100%. Andrew, I've watched your many speeches in the Commons and followed those written questions and I think for our UK viewers and listeners who are very frustrated at UK politics, I think as long as there remains someone like you speaking this truth, then there is hope. So thank you for what you do and thank you for your time today. Thank you very much for having me on. I'm sure we'll speak again in the future.

Last month, the Central government, in an affidavit to the Supreme Court, said that it cannot be held liable to pay compensation for deaths caused by adverse reactions to the COVID-19 vaccine. The affidavit was filed in a case in response to a petition filed by the parents of two young women, who allegedly died due to adverse reactions following their taking the COVID-19 vaccine. The Centre also said that taking the COVID-19 vaccine was purely voluntary and that the government had made all the relevant information about the vaccines freely available in the public domain. AstraZeneca's vaccine or Covishield as it is known in India, which was the vaccine largely used in the country's immunisation drive, is reported to be linked to a rare blood clotting condition, known as TTS – the United Kingdom in fact offers alternative vaccines to healthy adults under the age of 40.  The Centre said that a total of 26 TTS cases were reported, of which 14 recovered and 12 died. Other countries offer compensations to those who are injured following a vaccination: during the COVID-19 vaccinations, the World Health Oganisation introduced a “no fault compensation programme” as part of its Covax initiative. As of last month, India has administered nearly 220 crore doses of the COVID-19 vaccine, since the vaccination drive began in January 2021. As per the Centre's affidavit, a total 92,114 cases of adverse events following immunisation (AEFIs) have been reported in this period, which amounts to 0.0042% in terms of adverse events against the number of doses given. Of these, 89,332 have been “minor” cases while only 2,782 cases or 0.00013% are serious and severe. But how robust is India's system of reporting adverse events following immunisation? How easy or difficult is it for patients to report an adverse event, and do most people know how to do so? How much communication was there with regard to possible effects of taking vaccines? And while vaccine injuries are rare, and vaccines are necessary for public health initiatives, what happens to families of those who fall sick or lose their lives following a vaccination? Should the government, ultimately, take responsibility?

Somewhere in May last year, when the second wave of pandemic was in the full swing, India was struggling to vaccinate its people. The government and vaccine makers were trading charges while Covid-19 was taking a heavy toll on human lives. India, which was home to the world's largest producer of Covid-19 vaccine, failed to inoculate the entire population during the course of that lethal wave. But a few months on, by the month of July, India became the only country after China to administer over two billion Covid vaccination doses. The vaccination drive, on scale, was hailed as one of the best in the world. So far, over 98% of adults have received at least one dose of the Covid vaccine, while 90% have been fully vaccinated. Nearly 22.7 million doses are available with states as of October 1. And just about 15 months later -- by the end of September -- over 100 million doses of vaccines ended up being wasted as their shelf life expired. Were there no takers of these booster doses or they simply didn't reach the needy? The loss, pegged at Rs 2,250 crore, fades in front of the loss it may have cost to people's health as the world is still facing acute vaccine inequality. The shelf life of Covishield is currently nine months, while that of Covaxin is 12 months. The shelf lives of both the vaccines were extended by three months last year. Non-Covid vaccines typically have a shelf life of three years. Why were 100 million doses wasted? As the pandemic waned, people became complacent. Masks disappeared from public places and there were few takers for booster doses. Over 84% of India's population is eligible for booster dose, but only 27% of them have received the shot. The booster coverage improved, thanks to a 75-day free booster dose campaign by the Centre. In mid-July, the booster dose coverage was at a meagre 8%. Despite the gains, India still has a long way to go in improving booster coverage. Had it not been the free booster dose campaign, the wastage would have been higher. In an interaction with Business Standard earlier, Adar Poonawalla indicated that he was trying to save around 50-100 million doses of vaccines in a free booster dose drive. Some amount of vaccine wastage is inevitable with such a large vaccination drive, however, governments try to minimise the damage. For all vaccines, GAVI recommends countries to keep the maximum wastage of 25% for the first year, with gradual reduction to 15% by the third year. For Covid vaccines, GAVI assumed the wastage rate could be 10%. If we look at the global scenario, the number of Covid-19 vaccines which are likely to have been wasted since the global roll out began is estimated to be 1.1 billion as of mid-July, according to data analytics firm Airfinity. “While wastage at any level is undesirable, it is the result of unprecedented vaccine production which has saved millions of lives. If we want a fast reacting global vaccine response system, we will have to accept some level of wasted doses,” says Airfinity CEO, Rasmus Bech. The other major reason why so many doses ended up being wasted in India was because of mis-anticipation of demand. Experts say companies were unclear about the purchase orders from the Centre and ramped up capacity in a big way. Serum had accumulated 250 million doses of formulated vaccines, and another 250 million in the bulk form by December last year and stopped Covishield production. Bharat Biotech too had a stock of 50 million doses lying at its plants around April and had halted production of Covaxin. The restrictions on exports did not help either. As India grappled with a deadly second wave in April last year, the government halted vaccine exports and resumed only towards the later end of the year. The restrictions meant that vaccine makers might have missed out on some of the export orders.  Prof Y K Gupta, member of the National Expert Group on Vaccine Administration for Covid-19, tells more Prof Y K Gupta, For

radio mattoli 90.4 fm - aswathi murali --- Send in a voice message: https://anchor.fm/radiomattoli/message

Is Episode mey suniye, Covishield aur Covaxin ke booster dose ke daamon mein badi giraavat, Sonam kapoor aur Anand Ahuja ke Delhi wale ghar mein hui chori, CSK vs SRH : maidaan par utarate hi Ravindra Jadeja ne apne naam kiya bada record, MS Dhoni aur Suresh Raina ki list mein hue shaamil.

Bharat Bandh strike has led to a partial disruption of banking and transport services, Covishield dosage gap to stay at 12-16 weeks, There will be heat waves across northwest India over the next 2-3 days & other top news in this bulletin.

The Andaman and Nicobar Islands are likely to see heavy rain amid alert over Cyclone Asani, The gap between two doses of Covishield could be reduced to 8-16 weeks from 12-16 weeks now, Akshay Kumar has revealed the most difficult part of shooting for Bachchhan Paandey & other top news in this bulletin.

On January 3, India began vaccinating a section of its teenagers, with Covaxin. About 7.4 crore children, between the ages of 15 and 18, are eligible to receive the COVID-19 vaccine. As of Saturday, over 2 crore children had received the first dose of their vaccine. Only Covaxin was approved for use in this age group, even though, last October, India's first DNA vaccine, ZyCoV-D, had been granted emergency use authorisation for use in children above the age of 12. Some experts have argued that since COVID-19 in children is, in general, not severe, the entire adult population should have been vaccinated first -- over 90% of the eligible population has received the first dose, but second dose coverage remains less than 70%. However, others have pointed out that now that adult vaccination is well underway and progressing, the programme needed to be opened to children as well. India has also announced precautionary doses -- a third dose of the vaccine -- for healthcare and frontline workers as well as adults aged above 60 with co-morbidities. The move comes amidst a global surge in COVID-19 cases, with new variant of concern, Omicron, dominating. Unlike some other countries however, India will give beneficiaries the same dose they had for the first two -- either Covishield or Covaxin, without any mixing of the vaccines. So how did the children's vaccination programme come about, and how is it progressing? Do all adults need a booster dose or will only those at risk require it at present? How does the precautionary dose help protect vulnerable individuals? And will we see more variants in the future? Guest: Dr Srinath Reddy, President of the Public Health Foundation of India Host: Zubeda Hamid Edited by Reenu Cyriac

So far, about 63% of adult Indians have received both the doses of Covid-19 vaccines. And more than 90% have got at least one dose. India has majorly relied on the viral vector vaccine Covishield for its vaccination drive. Over 88% of the doses given out so far have been of Covishield, the Oxford-AstraZeneca vaccine manufactured locally under licence by the Serum Institute of India. Covaxin accounted for just a fraction. The two new vaccines approved for emergency use last month are Serum Institute of India's Covovax and Biological E's Corbevax. With last month's approval, the country now has eight vaccines in its kitty. Apart from the four discussed earlier, the remaining four are -- Sputnik V, ZyCoV-D, Moderna and Johnson and Johnson. Covishield uses the viral vector technology, while Pfizer and Moderna vaccines are based on messenger RNA or mRNA. Vaccination in western countries has been led by mRNA vaccines. Let us see what all vaccine platforms we have - Broadly, there are four types of platforms which are used in making the vaccine worldwide. They are RNA, viral vector, inactivated virus and protein-based platforms. Here, we are discussing the two most popular platforms on which most vaccines have been developed. They are viral vector and mRNA platforms. Let us understand the difference between the two, starting with the viral vector vaccine. But before that, let us understand that coronaviruses are named so because of the crown-like spikes on their surface, called spike protein or S protein. These spike proteins are the most used target for vaccines.  Viral Vector vaccines Now, let us understand what a viral vector vaccine is. It uses a harmless version of a different virus, called a “vector,” to deliver information to the body that helps it protect you. Genetic material from the target virus, in this case the Covid-19 virus, is placed inside the viral vector.  Once it enters a person's cells, it gives the cells instructions to make harmless copies of the spike protein. As the cells display the spike protein on their surfaces, the immune system starts producing antibodies and a type of white blood cells to fight off what it believes is an infection. If a person is later infected from the Covid -19 virus, these antibodies are already there to fight them. The vaccine doesn't contain the Covid -19 virus or the viral vector virus. Moreover, it does not change the DNA in any way. Covishield, Oxford-AstraZeneca, Janssen (J&J) and Sputnik V and Sputnik Lite use this platform. mRNA vaccine While mRNA vaccine uses genetically engineered messenger RNA created in a laboratory to teach our cells how to make a harmless variant of the spike protein that is found on the surface of Covid-19 virus. The presence of a foreign protein triggers a normal immune response, which produces antibodies that protects us from infection if the real virus enters the body. The vaccine is made of mRNA wrapped in a coating called the lipid nano-particle that makes the delivery easy and keeps the body from damaging it. And just like the viral vector vaccine, mRNA vaccine does not contain any virus, so it cannot give you an infection. After the mRNA delivers the instructions, our cells break it down immediately. Pfizer-BioNTech and Moderna use this technology to fight off the virus.  Watch Video

Most of us got our second and last jab months ago. Experts say that the immunity offered by Covid-19 vaccines wanes with the passage of time. So, as the third wave is threatening to take the world into its grip again, nations are mulling administering a third dose to its vulnerable population. And India, which on Tuesday logged 1.68 lakh new Covid-19 cases and 277 deaths, has started vaccinating its population which is above 60 years of age and have comorbidities. The booster shot is no different from the earlier doses which we had. It elicits an immune response from our body leading to production of antibodies, which in turn help the body fight the virus. Meanwhile, there is no consensus on whether the booster shot should be different from the earlier two jabs that one had. Citing several experts, DownToEarth magazine recently said in an article that there is no peer-reviewed study in India on the efficacy of mixing vaccines. In July last year, The World Health Organization's chief scientist had asked individuals against mixing and matching Covid-19 vaccines. He said that such decisions should be left to public health authorities. On the other hand, pointing to a study in the UK, BBC had last year said that a mix-and-match approach “appears to give good protection against the pandemic virus”. Some other studies have suggested that mixing-and-matching offers an even better immune response than using the third dose of the same series.  Back home, the Indian government is staying away from mix-and-match policy for the booster dose for now. For those fully vaccinated with Covishield, protection against fresh infection is just 3%. Protection against serious disease caused by Omicron is 18%, and against death 29%. Now, with a booster dose, this will increase to 80% protection against serious disease, and 88% against death. Medical experts have also suggested that the government should reduce the gap between two doses of vaccines from the present 84 days or 12-16 weeks. This would ensure speedier full vaccination of the entire eligible adult population. The Centre has, though, said that the interval between the second and third doses will be nine months.  The decision to keep the interval between the second and third doses at nine months has been based on the findings of five scientific studies carried out by the Indian Council of Medical Research (ICMR) and the Translational Health Science and Technology Institute (THSTI), Faridabad.  The third shot will for sure offer some shield to the elderly and the frontline workers from this ongoing wave of pandemic, even if it is from the same series. Watch video

Falguni Nayar In the male-dominated clique that is India Inc, few women have gained entry. India's women labour participation rate is just 21%, and one would be surprised that even in the upper echelons of the Indian business world, with all their talk of gender inclusion, female representation is dismal. In 2019, out of 1,814 chief executives and MDs of NSE-listed companies, only 67, or 3.69% were women. And last year, India had just one woman chief executive among Nifty50 companies, just as in 2019. Given this state of affairs, Nykaa CEO Falguni Nayar, much like her startup, is a unicorn. The entrepreneurial bug bit her when she was 50. And the online internet beauty business was a complete break for Nayar, who came with 18 years of experience as an investment banker with Kotak Mahindra.  In November this year, nine years after being founded in 2012, Nykaa's parent company FSN Ecommerce Ventures listed on Indian bourses. While 2021 saw several startups going for IPOs, Nykaa was one of the rare ones that was profitable.    As Nykaa's valuation crossed the Rs 1 lakh crore mark after its public listing, the net worth of Nayar, who owns around 52.56% stake in the company, surged to $7.90 bn. In the process, Nayar, an alumnus of IIM Ahmedabad, has become the wealthiest self-made woman in India and is among the country's 20 richest people, the only woman in this all-boys club, or as various publications have called it: the Nykaa among Nayaks. Adar Poonawalla Someone who is on the Time Magazine's “100 Most Influential People Of 2021” list, is an obvious choice for this wrap. The only son of Cyrus Poonawalla -- who established the Serum Institute of India (SII) in 1966-- Adar Poonawalla was sent to boarding school in London when he was nine years old. Adar returned over a decade later with a degree in business management from University of Westminster and joined the family business in 2001, without even an official designation. The next decade was spent under the shadow of his father, before Poonawalla became CEO of the company in 2011. And his moment of reckoning took almost another decade to arrive, when the world was under the grip of pandemic. Rising to the occasion, Poonawalla took a “calculated risk” and ramped up vaccine production, without waiting for government sanctions. The 40-year-old pumped in around $800 Mn into his company's Pune facility to manufacture millions of doses of the then unproven AstraZeneca vaccine against Covid-19. At the beginning of this year, SII delivered its first batch of AstraZeneca/Covishield vaccines for the Indian population. As of now, over 80% of the Indian population has received at least one shot. And over 90% of them had rolled up their sleeves for Covishield.   But Poonawalla had his share of controversies. His plan of exporting a large chunk of its Covishield output hit a roadblock when the deadly second wave of Covid-19 hit India in April. By that time, just about 2% of India's population was fully vaccinated. India banned the export of vaccines, hitting the supply of Covishield to poorer countries. While many hailed Poonawalla for SII's role in India's vaccination drive, global commentators flagged what they called lack of transparency in his statements. In June 2020, Poonawalla had said that his company would manufacture one billion doses of Covishield for low and middle income countries, of which, 400 million would be ready by the end of 2020. But, in January 2021, SII had a stockpile of just 70 million doses. Poonawalla also faced criticism for offering the vaccine at different rates to the Centre and the state governments. Nevertheless, as the year draws to a close, Poonawalla's, and consequently, India's worries, seem to have eased somewhat. The company recently announced that it will reduce Covishield production by half as it has fulfilled its orders to the Indian government and has a stockpile of 500 million do

India's Omicron case tally reached 578 on Monday, although no death has been reported so far. And the active cases stood at 75,841. The trend is similar, and the period too. The end of 2020 was also marked under the shadow of Covid-19, which took a deadly turn by March-April, claiming lakhs of lives.    So, as the world is venturing into another unknown territory, nations are taking steps to avert what is known to all now -- the havoc that the pandemic can cause. The WHO chief Tedros Adhanom Ghebreyesus has summed it well: ‘An event cancelled is better than a life cancelled.' But amid all this, businesses and the livelihood of crores of people are also being affected. The Federation of Hotel & Restaurant Associations of India (FHRAI) estimates that over 20-30% of establishments in the organised sector comprising around 60,000 hotels and 5 lakh restaurants have already shut shop since the outbreak of the pandemic. On Monday, the Centre issued another set of advisory to all the states and UTs, saying that they may consider imposing need based, local curbs and restrictions, to control the crowd during the festive season. Several states including Delhi, UP and Maharashtra have already imposed night curfew. Mumbai civic authorities have banned New Year celebrations in closed or open spaces. Starting January 1, Haryana is banning access to public places for both the unvaccinated and single-dose vaccinated.  While dozens of countries have started giving booster shots, India will start administering them as a precautionary measure to healthcare and frontline workers from January 10. It all has come at a time when the hospitality sector was steadily inching towards some normalcy. The earnings in the New Year would have given the sector a much-needed breather. Hotels have been seeing above normal bookings over the past few months as revenge travel after the second wave unleashed the pent-up demand.  But they now stare at cancellations due to increased restrictions. The government has also extended the suspension of scheduled international passenger flights till January 31. Contact intensive sectors like hospitality and tourism are always the first victims of a lockdown. India's domestic tourism saw a healthy uptick after August. Airports were choked and restaurants in tourist places were seeing a full house. December is the busiest period for hotels with Christmas, New Year and the wedding season all coming together. So far, hotels have not seen large-scale cancellations as the number of active cases is low. But a further rise may lead to another round of lockdowns.   In all of this, there could be a silver lining. A third dose of the Covishield vaccine significantly boosts antibody levels against the Omicron variant, its inventors AstraZeneca and Oxford University have said.  Covishield accounts for 90% of the vaccine doses administered in India. While there are doubts on the effectiveness of booster doses, opting for a lockdown instead will not only stop the economic recovery but push more small businesses towards closure. Watch video

As India grapples with the possibility of a new wave due to the Omicron variant, the Centre on Saturday, 25 December, announced an expansion of the national vaccination drive. In a late-night address on Christmas, PM Modi announced that those aged between 15-18 years of age will now be eligible for vaccinations from 3 January. “Precautionary doses” of a COVID vaccine will also be administered to frontline workers and those who are 60 years and above with comorbidities will be administered doses from 10 January. Though the decision to expand vaccination coverage has been widely welcomed, four critical questions regarding them have emerged: First, why call it a precautionary dose and not a booster dose? Does this signal that the third shot will be Covishield or Covaxin? This leads us to the second question, how effective is a third dose of the same vaccine? Third, given that Covaxin is the only vaccine in production to be cleared for inoculating those under 18, is it worrying that there is no publicly available data of the trials? And lastly, will the restriction on additional doses for those over the age of 60 cause problems? Guests: Dr Chandrakand Lahairya, an epidemiologist and health systems expert. Dr Rakesh Mishra, former director of the Center for Cellular and Molecular Biology. Host and Producer: Himmat Shaligram Editor: Eshwar Ranjana Music: Big Bang Fuzz Listen to The Big Story podcast on: Apple: https://apple.co/2AYdLIl Saavn: http://bit.ly/2oix78C Google Podcasts: http://bit.ly/2ntMV7S Spotify: https://spoti.fi/2IyLAUQ Deezer: http://bit.ly/2Vrf5Ng Castbox: http://bit.ly/2VqZ9ur

AstraZeneca, a British-Swedish pharmaceutical firm that has become popular in India due to its COVID-19 vaccine Covishield, has tied up with Bengaluru-based health-tech startup Tricog for Project Heartbeat in the country. In this edition of the Medicine Box season 5, CNBC-TV18's Ekta Batra gets in conversation with Dr Anil Kukreja, Vice President, medical affairs and regulatory, AstraZeneca about the project that aims to ensure early and accurate diagnosis of possible heart attacks of patients in Tier 2 and 3 cities. Dr Kukreja noted early diagnosis and timely treatments are critical for heart attacks. With the project that has been piloted in eight hubs and 39 spokes across India, patients in Tier 2 city can have their electrocardiogram (ECG) test read by a qualified cardiologist. The tech for Project Heartbeat has been created with ECG machines and communicators. The communicator sends ECG reading to a cardiologist who provides the diagnosis in a matter of minutes, Dr Kukreja explained. “The focus is to reduce ‘Door to Needle' and ‘Door to Balloon' time,” the top AstraZeneca official said, adding that they are trying to train healthcare practitioners and technicians to ensure accurate medications in time. Tune in to The Medicine Box Podcast for more 

Today's information is astounding! India is fed up with the Bill and Melinda Gates Foundation and for good reason. In today's video, learn how Gates' partnership product Covishield has some deadly side effects. India is convinced and they're seeking the death penalty! --- Support this podcast: https://anchor.fm/christopher-morris2/support

The threat of a fresh Covid-19 variant is looming large and half of the country's population is yet to be fully vaccinated. Adding to the woes, Pune-based Serum Institute of India has now announced that it will reduce the production of the Oxford-Astra­Ze­neca vaccine, marketed as Covishield in India, by at least 50 per cent from next week. The vaccine maker says that it does not have fresh orders from the Indian government. And if we factor in the possibility of a booster dose, then the vaccine shortfall could only increase. Let us see how much stock we are left with and what is the road ahead.  Serum CEO Adar Poonawalla said that the company has about 500 million doses of Covishield left in stock. And half of it is in an unfinished state. Poonawalla said SII will start exporting the available stock if the Indian government doesn't need the supply. And on Tuesday, the government told the Parliament that 227.6 million doses were available with the states as on December 1, 2021. A Business Standard analysis shows that the government, on December 1, did not have enough doses to administer a second jab to people who have not been fully vaccinated and vaccinate the remaining unvaccinated individuals. Of the 36 states and UTs for which data is available, only 11 states had enough doses to cover their partially vaccinated population with a second dose and the unvaccinated people with first doses. Uttar Pradesh, for instance, had a shortfall of 67.7 million doses, while Maharashtra and Bihar were short of over 25 million doses each, as on December 1, 2021. Tamil Nadu and West Bengal were short of nearly 20 million doses during the period. Serum Institute of India's 500 million doses of Covishield -- if they have been prioritised for the Indian government--plus the stock of Covaxin with Bharat Biotech, should be enough to fulfill India's vaccination requirements for the adult population.  However, if India goes for an additional dose for the fully vaccinated population or a booster dose, then there might be a shortfall. This shortfall in vaccines is particularly telling when we still don't know how the Omicron variant of coronavirus will act up. Medical experts and epidemiologists have warned that Covid-19 will become endemic and people will require annual booster shots. And India is yet to take a final call on vaccinating children. Given all these uncertainties, the country cannot afford disruption in supply of vaccines. Watch video

The world's largest vaccine maker, Serum Institute of India, has said that it is going to cut the production of Covishield by half as there was no fresh order from the government. But, according to data, some of our larger states such as Uttar Pradesh and Maharashtra don't have enough stock to fully vaccinate their adult population.  Pandemics are not the only disrupters which throw normal life out of gear and hit businesses. Internet shutdowns also have similar ramifications. Recently, India earned the dubious distinction of being the “internet shutdown capital” of the world. According to a report, the country lost an estimated $2.8 billion last year due to the internet blockades, which experts believe was unwanted in most cases.  From India's internet shutdowns, let us see what its central bank is doing to revive the growth. The Reserve Bank of India delivered its bi-monthly monetary policy yesterday. It kept the key interest rates unchanged amid the rising uncertainties due to the new coronavirus variant. The RBI also kept GDP projections unchanged and flagged near-term inflation concerns. The move, analysts say, highlights a bumpy road ahead for the economy.  In another good news for the market, the one-month lock-in period for anchor investors in newly-listed companies Nykaa, Paytm, PolicyBazaar and seven others ended on Wednesday. So, what is this lock-in period and why SEBI has proposed to increase it? Finf out all these and more in this episode of the podcast. Watch video

Prasad Kulkarni, Medical Director of the Serum Institute of India, discusses his recent phase 2/3 trial on the Covishield vaccine published in eClinicalMedicine, as well as its implications for COVID vaccine development in general. 

According to Dr Subhash Salunkhe, one reason for increasing Covishield dose gap was vaccine shortfall, says ‘there should be more latitude in this now that situation has eased'.

As early as this month, India may see the rollout of ZyCoV-D, the world's first DNA vaccine against COVID-19. Pharmaceutical company Zydus Cadila has received Emergency Use Authorisation for this vaccine, which is also the first in the country to be approved for children above the age of 12. How do DNA vaccines work, and how are they different from the vaccines we have now -- Covishield and Covaxin? What sort of immunity will the DNA vaccine provide? Will the three-dose regimen pose a problem, logistically, in administering ZyCoV-D? Sero-surveys across the country have shown us that in the most populated of regions 70% of the population may have COVID-19 antibodies already -- what does this mean for children, and do they need to be necessarily vaccinated at this stage? Guest: Dr Gagandeep Kang, Professor of Microbiology at Christian Medical College, Vellore. Host: Zubeda Hamid

In this latest SBS Hindi News bulletin of Australia and India: New South Wales Premier Gladys Berejiklian's shock resignation over a corruption inquiry; The Prime Minister outlines details for Australia's plans to resume international travel; India denies China's allegations saying "no basis in facts" and more news

After vaccine nationalism, are India and the developing world suffering vaccine racism? This week, the UK is easing restrictions for travellers from a number of countries, who will not have to undergo mandatory quarantines, if they have taken a recognised vaccine. Indian-made Covishield, an Astrazeneca variant is on the list of approved vaccines after a major protest by India but India itself is not yet on the list of countries that will be given the exemption. Simply put, if you have been vaccinated in India, you will have to quarantine for 10 days and test negative twice in order to be allowed out in the UK. This is indeed a long way from January this year, when PM Boris Johnson and PM Modi were expected to announce a vaccine partnership using Indian manufacture and British expertise to produce vaccines for the world. At the UN, PM Modi said he was proud of India's vaccines: DNA, MRNA, and soon a nasal vaccine. The British rule has been taken up by External Affairs Minister Jaishankar with his UK counterpart Liz Truss, and Foreign Secretary Harsh Shringla said the rules are discriminatory and would incur reciprocal action from India Read on why it is a discrimination and more here

During his trip to the United States, Prime Minister Narendra Modi said that international travel should be made easier through mutual recognition of vaccine certificates. Well, it was apparently a message for countries that have different yardsticks for different countries when it comes to vaccine certificate acceptance.  Now, let's put this in context. After India warned of reciprocal measures, the United Kingdom finally recognised Covishield. However, the travails of Indians travelling to the UK aren't over.  The country, which appears to have doubts over vaccine certification in India, has not removed the home isolation requirement for vaccinated Indians and has sought details regarding the working of the CoWin app. So, it means that Indians would have to self-isolate for 10 days upon arrival in the UK, even if they are fully vaccinated with Covishield. That sounds unfair, doesn't it? A large chunk of vaccine doses that have been administered in the UK so far were exported from India by Serum Institute. And, shouldn't the focus at this point be on a coordinated approach among governments to revive global travel and tourism, a sector that has suffered the most due to the pandemic? How much money have airlines lost? According to an International Air Transport Association report, airlines collectively lost $6.9 billion in the April-May period of 2021, compared with $14.4 billion in the first quarter of the year. IATA earlier this year forecast a $48-billion loss for member airlines in 2021. Just think about someone planning to visit the UK for business or leisure. With this 10-day quarantine rule, not many would be in a position to take the cost burden. And also the broader implication if countries faced with such restrictions started reciprocating by imposing similar curbs. Won't that lead to a huge impact on global trade, commerce and travel, and also put roadblocks in the global economic recovery? Meanwhile, India is looking for solutions by engaging bilaterally with countries for a mechanism to mutually recognise each other's vaccine certificates. In an oped column for a business daily, National Health Authority Chairman and head of the Cowin app, R S Sharma, wrote that they are planning to release an international version of the vaccination certificate for travel purposes. Let's look at the key takeaways from his column to get a sense of India's future plans for addressing the trust deficit. R S Sharma on vaccination certificate: He wrote that people could soon log on to the CoWIN portal and apply for International Vaccination Travel Certificate, or IVTC. These certificates would soon be available for download in various internationally accepted formats. There will also be a facility for beneficiaries to link their passport to IVTC using the CoWIN app. Here's what economic analyst Pranjal Sharma said on these steps for building trust around vaccination certificates: Countries should come together if they want travel & tourism to be improved Harmonise the protocols for vaccination, certification and recognition It should be possible across countries to read, scan and validate QR codes So, if we want the world to prosper as one, and not as individual nations, as Pranjal suggests, there needs to be uniformity in travel rules across the world.

Oil prices have climbed steadily in the past few weeks, with Brent crude crossing the $80-a-barrel mark recently for the first time in three years. Research houses like Goldman Sachs expect the Brent to hit the $90-a-barrel mark by the end of this calendar year. So, why is oil on the boil? How are the demand-supply dynamics shaping up? What does all this mean for the Indian markets and the government's revenue maths? Listen to this podcast for the answers and an exclusive interview with Dr Kang Wu, the head of global demand and Asia analytics at S&P Global Platts. *** It's the IPO season. A bunch of listings like Zomato's have been stellar. And another group, including Paytm, Oyo and Policybazaar, is ready to hit the gong. For countries like India, it is pertinent to attract tech start-ups to list in India and Not go overseas. So, India is tightening the lever on policy. Markets regulator SEBI has eased the rules for issuance of shares with superior voting power - a long-time ask of the tech ecosystem. India is now on a par with start-up rules in the US and broader west. Is it enough to spur start-up IPOs? Or is it an incremental step?  *** Did you know that people from 18 countries, including Denmark, Canada, and Antigua and Barbuda, who are vaccinated even with Covishield can travel to the UK without following mandatory quarantine protocols? But not Indians... they will have to go through a 10-day self-isolation. Many countries are adopting different sets of rules to allow foreigners to enter their territory. Does this not impact the global business prospects at a time when we all are looking for stronger and faster economic recovery? Isn't it time to have conformity and trust in approved vaccines?  *** We hear a lot about 5G telephony these days and come across so many devices that claim to be 5G-ready. But what is 5G really? And how does it work? Learn about 5G and the three basic parameters that define 5G. *** Listen to these and more in today's edition of the Business Standard Morning Show podcast.

Global News Watch-Updates on the Taliban's control in Afghanistan -Chinese media sets sight on Taiwan as US' Afghanistan retreat strokes nationalism -1.2 million people affected by Haiti earthquake -Covishield: WHO flags fake jabs in India and Africa -아프간 내 탈레반 세력 확장 및 상황 업데이트-미군의 아프간 철수 이후 대만에 대한 중국 언론의 움직임 -아이티 지진으로 인한 사망자 및 사상자 업데이트-인도와 아프리카 내 가짜 코비실드 접종을 발견한 세계보건기구 Guest: Jee Abbey Lee, ReporterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Every week it seems like more and more jaw-dropping news is coming out about Covid shots. On this episode of Objective:Health, we cover the latest news on the mRNA and other shots, including: Dr. Yeadon warning that children are 50 times more likely to die from the vaccines than from Covid; Mercola reporting that to prevent three deaths the Covid jab kills two; rare autoimmune hepatitis coming from the Covishield vaccine and a British report calling for an the end to the Covid vaccination...

There was a time when we got vaccinated and never knew the name of the company on the label, and never asked. But today, Covishield vs. Covaxin is like Shah Rukh vs. Amir Khan or Apple vs. Android. To many, criticism of Covaxin is anti-national. For others, Covaxin is as effective as right wing propaganda. The truth, as usual, is hostage to polarizing narratives and political messaging. A day after Bharat Biotech released Covaxin phase 3 results as a pre-print, with peer review and YouTube comments pending, we delve into the topic. Your hosts: Kanishka Chatterjee (KC) & Sharath C George (SCG). --- Send in a voice message: https://podcasters.spotify.com/pod/show/the-viral-truth/message

A version of this article has been published by rediff.com at https://www.rediff.com/news/column/india-blundered-along-like-others-did/20210623.htmThere is a loud chorus of voices blaming India for somehow messing up its response to the massive wave of Wuhan virus (Covid-19) infections that have devastated the country. Many articles and editorials have come out in both the Indian media and western media suggesting that the Government of India was negligent, indifferent, or both; in effect that it criminally abdicated its responsibility to the people of India. It is normal to expect these cavils from political parties and from the mainstream media. In India the MSM is highly compromised and infiltrated by vested interests, both from local political parties and from foreign powers set on propagating a narrative that leads, inevitably, to regime change, and, preferably, balkanization. One of these outbursts was an editorial in the Lancet, a British medical journal, that puts the blame squarely on the GoI (with no blame attributed to the State governments, despite the fact that health is a State responsibility). I used to be impressed by the Lancet as essentially the paper of record in medicine, but a massive screw-up last year in regards to HCQ made me change my mind, and realize that politics takes precedence over science.I wrote a long essay, Pious Frauds, https://openthemagazine.com/essay/pious-frauds/ about how credentialism rather than scientific truth is the hallmark of some of these storied institutions. The Lancet has been in the middle of several serious frauds, and it is astonishing that they still have a sterling reputation. So I would take their opinions with a large grain of salt, unless supported by impeccable data/evidence, which it is not in this case. Even purportedly neutral scientists and labs labor under agendas.Here’s more on bad faith from the Lancet. Much the same happened with another cheap, off-patent drug, Ivermectin. In both these cases, it was not at all convenient for Big Pharma that cheap, generic drugs made mostly in India would eat into their windfall profits. Let us note that Pfizer made a profit of $15 billion in 2020. Moderna made a profit for the first time in its history in Q1 2021. Also, Gilead Pharma’s Remdesivir, that was pushed as some sort of panacea, but in the event it proved mostly useless.Another case in point is the increasingly vocal allegation that the US government in effect colluded with the Wuhan Institute of Virology to do gain-of-function research in bat coronaviruses, which made them far more potent as well as transmissible to humans. Anthony Fauci, Peter Daszak, and others look like they concealed conflicts of interest and deliberately propagated the narrative that the Wuhanvirus must have evolved naturally. Nicholas Wade’s seminal essay, republished by the Bulletin of Atomic Scientists, is a scathing indictment of the media and its omerta in burying an important story that somehow didn’t fit their narrative: the lab-origin hypothesis, and in particular the conflicts of interests. See https://nicholaswade.medium.com/origin-of-covid-following-the-clues-6f03564c038 and a video version at https://unherd.com/thepost/nicholas-wade-the-case-for-the-covid-lab-leak-theory/It looks increasingly likely that the Wuhanvirus was developed in a lab and was either leaked because of poor security in BSL-2 and BSL-3 labs, or, more alarmingly, that it was deliberately released as a bio-weapon. That is significant, for a variety of reasons: of most concern, the possibility of bio-warfare, which would be considered a crime against humanity, considering almost every country has signed treaties against it.On a more mundane level, it means that the Wuhanvirus outbreaks are in effect, force majeure, by definition things that cannot be defended against or predicted, as they are unpredictable and out of the expected set of possible scenarios. All of us, individuals and societies alike, make plans based on events with a non-trivial probability. When an extremely improbable event hits -- Nassim Taleb famously called these Black Swan events -- it is beyond the scope of our normal strategic planning. This goes hand-in-hand with the sensible engineering principle of built-in safety factors. For instance, an engineer designing anything, a bridge, an aircraft, or a circuit, will assume a certain level of uncertainty, and build in some slack say 30-50% over the designed load. This enables the system to be resilient in the face of a sudden surge or stress on the system. But there are practical limits to how much safety you can build in, because there is a cost to it. You can design in 100% or 200% margins of error, or more, but these start to get expensive. There is a tradeoff: so you take an informed decision about the expected value of the maximum stress. That is what you engineer the system for.A good example is the Fukushima reactor in Japan. It was (I may be a little bit off on the numbers, but bear with me for the principle) built to withstand an 8.5 earthquake on the Richter scale. There have been no quakes greater than 8.2 for 500 years, or since accurate records started being maintained. So that seems like a fair tradeoff on cost and risk. In fact, no project manager will approve the budget for reinforcing it to withstand an 8.8 quake.But what happens if you get hit with a 9.0 earthquake? The system is overloaded, and all bets are off. There is catastrophic failure.This is more of less what happened to every health system in the world when the Wuhavirus struck. India is no exception. Neither was the US when it was going through its peak: a year later, there are still hundreds of unclaimed bodies stored in refrigerated trucks; and there were mass graves with tens of bodies buried on an island near New York City. Nor was Italy, when people were dying in droves on ventilators. Nor was Osaka, more recently.There is more: Thailand, Vietnam and several other countries, which had escaped the calamity earlier, are now showing signs of new outbreaks. The virus continues to ravage the world. So the first point is that it was not humanly possible to fend off the lethal virus, in particular the 617 or Delta variant, which was far more infectious in the second wave: its R0 was greater than 3 or even touching 4 in many places, which implies a combinatorial explosion in terms of infections. The second point is that India was complacent about how it had escaped catastrophe, and ‘boasted’ about how it was “vaccine supplier to the world”. There is some quote from PM Modi at the World Economic Forum that India had defeated the virus; this is trotted out by all and sundry to show hubris on the part of the Indian government. This reminds me of the ritual in Silicon Valley companies called “the massacre of the innocent”. After every failed project, there is a meeting to apportion blame. Some suitable bystander is anointed as the scapegoat, and the entire thing is blamed on him (it’s usually a man). The actual culprits who messed up are given a pass, and are sometimes promoted. The point is that if somebody made a reasonable decision, one that was appropriate given the information on hand at the time, cannot be blamed for the circumstances changing later. Hindsight does not count. Yes, one should anticipate, even war-game, for various scenarios, but you cannot be expected to be omniscient. By finding a scapegoat (which, historically, comes from a Middle Eastern custom of actually blaming a goat for all the ills that befall the village, and forcing it to wander off into the desert) you allow the real culprits to escape. This is what happens all the time in business, and surely elsewhere too.Given the circumstances after the first wave subsided around the end of the year, it really did look like the strict lockdown had taken the wind out of the sails of the virus, and India was expecting to produce large volumes of Covishield and Covaxin over the first few months of 2021. So much so that India would give away some doses to small developing countries, and sell a lot more to the Covax alliance that would in turn distribute to the developing world.Production levels at least for Covishield were seriously affected by a February 2021 (yes, Biden era) ban on exports of critical components under the US Defense Production Act. Belatedly, on June 4th, these restrictions were lifted. Here’s the New Indian Express’ coverage:India was being a good global citizen in providing free vaccine to small countries; the contrast with big developed nations could not be more dramatic -- the latter were ordering 3 or 4 times the total doses they needed. In addition, the US was hoarding 45 million doses of the AstraZeneca vaccine which isn’t approved for use in that country. Classic dog in the manger syndrome. There are loud commitments from the G7 to provide a billion doses of vaccine free of cost to poor countries. This is good, but as Ronald Reagan once said, “Trust but verify”. I’d like to read the fine print. Does this mean a billion doses of mRNA vaccines from Pfizer and Moderna? What about the sovereign guarantees required by Pfizer as well as indemnity against any claims of side-effects? Who is going to provide that?To sum it up, I have to fall back upon something from the Christian Bible: “let he who hath not sinned cast the first stone”. Not to say that India couldn’t have handled the situation better, but on average, it didn’t do anywhere near as badly as the naysayers make it out. It blundered along, exactly as every other country did. 1592 words, June 12th, 2021 This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit rajeevsrinivasan.substack.com

Dr Haryax Pathak, MBBS, practising in Vadodara, Gujarat, India, has been busting myths about COVID-19, its treatments and the vaccines on Twitter. He was kind enough to join Rationable to dispel myths about the vaccines and help us understand which one to choose, what the dosage interval should be, and lots more.Here are a the updates: 1) Immunocompromised people should also get the vaccine2) The central government has increased the period after which one should get Covishield's second dose to 6-8 weeks3) People over 18 will be allowed to get vaccinated from the 1st of May onwardsIntro and outro music: Heat by DistillFor the full transcript along with links to citations and further reading, please visit www.berationable.com. Questions, suggestions or just want to get in touch? Find me on Instagram and Twitter @berationable. Join the conversation on the Rationable Conversations Facebook group. Contact me at abhijit@berationable.com. For more content like this, visit www.berationable.com. Support and get involved with Rationable on Patreon at patreon.com/rationable.

No Papo Antagonista desta sexta-feira, Felipe Moura Brasil e Diogo Mainardi comentaram as mentiras do governo sobre o aplicativo TrateCov e a declaração de Jair Bolsonaro sobre a vacina. O programa trouxe ainda os detalhes da chegada das doses da Covishield no Brasil e os destaques da Crusoé.

No Papo Antagonista desta quinta-feira, Felipe Moura Brasil e Claudio Dantas comentaram a vinda das doses da vacina indiana Covishield para o Brasil. O programa trouxe ainda os detalhes da busca do governo Bolsonaro por insumos chineses para a produção dos imunizantes.

No Papo Antagonista desta terça-feira, Felipe Moura Brasil e José Nêumanne Pinto comentaram o início da vacinação pelo Brasil. O programa ainda trouxe os detalhes da trapalhada de Ernesto Araújo que empurrou o Brasil para o fim da fila da vacina indiana, Covishield.

disclaimer: i’m not antivaxx, but just want proper scientific validation of the effectiveness and lack of bad side-effectsindia approved the oxford astra zeneca vaccine, covishield, today 3 jan on an emergency basis. cold chain friendly and non-mRNA, adenovirus. the actual vaccine used in their trials was not produced by serum institute, but from some european labs. said India’s comptroller general of drugs, according to the ToI https://timesofindia.indiatimes.com/india/india-approves-oxfords-bharat-biotechs-covid-19-vaccines-for-restricted-emergency-use/articleshow/80081573.cms: bharat biotech covaxin may be better: traditional dead-virus vaccine. it has also been approved on an emergency basis. it is undergoing phase 3 trials right now. some concerns about issues between oxford university and astra zeneca, according to WSJ https://www.wsj.com/articles/astrazeneca-and-oxfords-bumpy-partnership-hangs-over-covid-vaccines-future-11609336498 (alas, firewalled)lancet paper at https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext has the data on astra zeneca’s vaccine several questions come up. first on the trials themselvesfour trials in the UK, Brazil, South Africa are described here. kenya trial mentioned in passing. what about the india trials done by serum institute of india, in which there were accusations and counter-accusations of side-effects? why isn’t this mentioned at all?they talk about pooled data of 20,000 patients, but in the data appendices, the total number of patients in the trials is only 11,636. does it mean that only 11,636 got the vaccine? or is it that placebo+vaccine = 11,636?if these trials are not complete, why is their interim data being put out?efficacy. not well defined. all the trial is testing for is if the person is seriously ill and has to be hospitalized, but it’s not really testing for:whether the person is NOT infected with the virus at allwhether the person is an asymptomatic carrierwhether the person is infected and is exhibiting mild symptomsthe serious confusion about 1/2 dose + full dose vs full dose + full dose. was this an accidental experimental error? the former got 90% efficacy, the latter 62% efficacy, and how can you lump the two and get a result of 70%? also, WSJ says:the trial RCT designtwo of the trials are single blindone of the trials is double blind. why this discrepancy?can you extrapolate from one to the other?trial participants, total 11,636, of which9625, ie 83% are white517, ie 4.4% are Asian (and what is the definition of ‘Asian’?)479, ie 4.1% are blackis that diverse enough?7045, ie 61% are female77.8% are healthcare and social services workers (not very diverse!)974, ie 8.4% are 56-69 years in age444, ie 3.8% are over 70 years in ageis that diverse enough? here are the co-morbidities:1241, ie 10.7% had cardio co-morbidity1360, ie. 11.7% had respiratory problems270, ie 3.9% were diabeticside-effects: there were 175 adverse effects, with at least three as possibly related to the vaccine. there were as many adverse effects (91) among the control group as there with the vaccinated group (84), so that suggests vaccine isn’t doing visible harmsummary findings: what about the p-values: one missing, the other is 0.01, ie 1% probability there is no correlation This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit rajeevsrinivasan.substack.com